TDS Pharm Co (XKRX:464280) Additional Paid-In Capital : ₩9,970 Mil(As of Mar. 2025)

View and export this data going back to 2024. Start your Free Trial

What is TDS Pharm Co Additional Paid-In Capital?

TDS Pharm Co's quarterly additional paid-in capital stayed the same from Sep. 2024 (₩9,970 Mil) to Dec. 2024 (₩9,970 Mil) and stayed the same from Dec. 2024 (₩9,970 Mil) to Mar. 2025 (₩9,970 Mil).

TDS Pharm Co's annual additional paid-in capital stayed the same from Dec. 2022 (₩0 Mil) to Dec. 2023 (₩0 Mil) but then increased from Dec. 2023 (₩0 Mil) to Dec. 2024 (₩9,970 Mil).

TDS Pharm Co Additional Paid-In Capital Historical Data

The historical data trend for TDS Pharm Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TDS Pharm Co Additional Paid-In Capital Chart

TDS Pharm Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Additional Paid-In Capital

9,970.14

TDS Pharm Co Quarterly Data
	Dec20	Dec21	Dec22	Mar23	Sep23	Dec23	Mar24	Sep24	Dec24	Mar25
Additional Paid-In Capital	Get a 7-Day Free Trial					-	-	9,970.14	9,970.14	9,970.14

TDS Pharm Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

TDS Pharm Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of TDS Pharm Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

TDS Pharm Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TDS Pharm Co Ltd (XKRX:464280) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

253 Pangyo-ro, Pangyo Inno Valley, Building C, Room 403, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13486

Website

https://www.tdspharm.com

TDS Pharm Co Ltd is engaged in the development and manufacturing of the Transdermal Drug Delivery System (TDDS), which is growing as a high-growth business sector in the field of drug delivery systems (DDS). The Transdermal Drug Delivery System (TDDS) is a drug delivery system that delivers drugs through the skin at a controlled speed. It has the advantages of increasing patient compliance with drugs, maximizing efficacy and effectiveness, such as minimizing side effects in the liver and digestive organs, controlling absorption rate, controlling discontinuation, controlling effective blood concentration, and enabling long-term continuous administration, and reducing burden compared to oral and injection drugs.

TDS Pharm Co Headlines

No Headlines